Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Why Is Sonos (NASDAQ:SONO) Stock Up 9% Today?

Sonos (NASDAQ:SONO) shares are extending their rally, continuing to climb as investors digest this week's launch of Sonos 27, the latest version of the company's audio operating system. Sonos is a Santa Barbara, California-based consumer electronics company that designs, manufactures, and sells premium wireless …

Vinay Lochav | 02 September 2026

Herbalife (NYSE:HLF) Climbs as Investors Digest Leadership Change

Herbalife (NYSE:HLF) shares are climbing further, continuing to build on gains from earlier this week as investors digest the company's planned leadership transition. Herbalife is a global nutrition company that develops, markets, and distributes wellness products across weight management, targeted nutrition, and energy and …

Vinay Lochav | 02 September 2026

Paramount Skydance (NASDAQ:PSKY) Rises 5% on Warner Bros. Discovery Deal Progress

Paramount Skydance (NASDAQ:PSKY) shares are trading sharply higher as investors focus on progress in the company's pending Warner Bros. Discovery acquisition financing. Paramount Skydance is a next-generation global media and entertainment company formed in August 2025 through theMergerof Paramount Global and Skydance Media, operating …

Vinay Lochav | 02 September 2026

Why Is Sphere Entertainment (NYSE:SPHR) Stock Up 5% Today?

Sphere Entertainment (NYSE:SPHR) shares are rising as investors respond to a wave of bullish analyst commentary. Sphere Entertainment is a premier live entertainment and media company operating through two core segments: Sphere, its groundbreaking immersive entertainment venue in Las Vegas, and MSG Networks, which …

Vinay Lochav | 02 September 2026

Why Is Charter Communications (NASDAQ:CHTR) Stock Up 7% Today?

Charter Communications (NASDAQ:CHTR) shares are rebounding sharply, recovering a portion of the prior session's selloff that followed news that Chief Financial Officer Jessica Fischer will step down on October 15. Charter, operating under the Spectrum brand, is a leading U.S. broadband connectivity company and …

Vinay Lochav | 02 September 2026

This NASDAQ Apparel Stock Falls 10% Today Despite Beating Earnings Estimates

G-III Apparel Group (NASDAQ:GIII) is trading sharply lower today even after posting fiscal second-quarter results that beat estimates on the bottom line, a reaction that runs counter to what would typically be viewed as positive news. The company reported non-GAAPEarnings Per Shareof $0.26, ahead …

Vinay Lochav | 02 September 2026

Dentsply Sirona (NASDAQ:XRAY) Rises 6% on Fresh Institutional Accumulation

Dentsply Sirona (NASDAQ:XRAY) shares are trading sharply higher as investors weigh fresh evidence of institutional accumulation following new 13F disclosures. Dentsply Sirona is a Charlotte, North Carolina-based company tracing its roots to 1877 and describing itself as the world's largest manufacturer of professional dental …

Nitish Kishor | 02 September 2026

First Tracks Biotherapeutics (NASDAQ:TRAX): What's Behind the Stock's 14% Rally Today

First Tracks Biotherapeutics (NASDAQ:TRAX) shares are trading sharply higher, briefly touching a new 52-week high, even as the company reported a wider-than-expected second-quarter loss. First Tracks is a San Diego-based clinical-stage biotechnology company, spun off from AnaptysBio in April 2026, developing next-generation antibody therapies …

Nitish Kishor | 02 September 2026

MiniMed Group (NASDAQ:MMED) Climbs on Raised Guidance and Institutional Buying

MiniMed Group (NASDAQ:MMED) shares are extending their post-earnings rally, climbing toward a fresh 52-week high after BTIG raised its price target to $28 from $25 while maintaining a Buy rating. MiniMed is a global medical technology company that develops, manufactures, and markets an integrated …

Nitish Kishor | 02 September 2026

This NASDAQ Gene Therapy Stock Slides 4% Today Despite a Landmark FDA Submission

uniQure (NASDAQ:QURE) is trading lower today even after submitting a Biologics License Application to the U.S. Food and Drug Administration and a Marketing Authorisation Application to the UK's Medicines and Healthcare products Regulatory Agency for its Huntington's disease gene therapy, a reaction that runs …

Nitish Kishor | 02 September 2026
Support

Hi! How can we help you today?

Loading…